(2014) A chaperone improves blood α‐glucosidase activity in Pompe disease sufferers treated with enzyme substitute therapy. Mol Ther In combination with condition mechanisms, NGS‐based analysis also has the potential to identify novel disorder biomarkers. This solution has become Employed in recent studies that determined microRNAs as markers of Pompe condition, https://psychedelics35678.qodsblog.com/27638944/pain-killers-an-overview